NASDAQ:SCNX - Nasdaq - US80880X1046 - Common Stock - Currency: USD
0.9211
-0.03 (-2.94%)
The current stock price of SCNX is 0.9211 USD. In the past month the price increased by 7.39%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
VEEV | VEEVA SYSTEMS INC-CLASS A | 36.43 | 39.17B | ||
DOCS | DOXIMITY INC-CLASS A | 37.59 | 9.94B | ||
WAY | WAYSTAR HOLDING CORP | 50.19 | 6.86B | ||
CERT | CERTARA INC | 23.86 | 1.89B | ||
SDGR | SCHRODINGER INC | N/A | 1.58B | ||
PHR | PHREESIA INC | N/A | 1.50B | ||
GDRX | GOODRX HOLDINGS INC-CLASS A | 11.68 | 1.43B | ||
TDOC | TELADOC HEALTH INC | N/A | 1.29B | ||
LFMDP | LIFEMD INC - LFMD 8 7/8 PERP | N/A | 1.08B | ||
EVH | EVOLENT HEALTH INC - A | 23.08 | 1.03B | ||
HSTM | HEALTHSTREAM INC | 45.48 | 874.68M | ||
CCLDO | CARECLOUD INC - CCLD 8 3/4 PERP | N/A | 840.05M |
Scienture Holdings, Inc. engages in the provision of health services and pharmaceutical products. The company is headquartered in Lutz, Florida and currently employs 14 full-time employees. The company went IPO on 2020-02-18. Scienture, LLC is focused on developing and commercializing products for the treatment of central nervous system and cardiovascular diseases. Scienture LLC is developing a range of product candidates, including new potential treatments for hypertension, migraine, pain and thrombosis and other related disorders. The firm's product candidates include SCN- 102 (hypertension), SCN- 104 (CNS-Pain), SCN- 106 (Cardiovascular) and SCN- 107 (Pain). SCN-102 is an oral liquid formulation of losartan potassium in development for the treatment of hypertension. SCN-104 is a multi-dose pen-based delivery system for self-injection and increased patient convenience, which is in development for the acute treatment of migraine headaches.
SCIENTURE HOLDINGS INC
2420 Brunello Trace
Lutz FLORIDA US
Employees: 14
Phone: 18002610281
The current stock price of SCNX is 0.9211 USD. The price decreased by -2.94% in the last trading session.
The exchange symbol of SCIENTURE HOLDINGS INC is SCNX and it is listed on the Nasdaq exchange.
SCNX stock is listed on the Nasdaq exchange.
SCIENTURE HOLDINGS INC (SCNX) has a market capitalization of 11.53M USD. This makes SCNX a Nano Cap stock.
SCIENTURE HOLDINGS INC (SCNX) currently has 14 employees.
SCIENTURE HOLDINGS INC (SCNX) has a support level at 0.88 and a resistance level at 1.01. Check the full technical report for a detailed analysis of SCNX support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
SCIENTURE HOLDINGS INC (SCNX) has a dividend yield of 168.35%. The yearly dividend amount is currently 3.08. Check the full fundamental report for a detailed analysis of SCNX dividend history, reliability and sustainability.
SCIENTURE HOLDINGS INC (SCNX) will report earnings on 2025-06-24.
The PE ratio for SCIENTURE HOLDINGS INC (SCNX) is 0.07. This is based on the reported non-GAAP earnings per share of 12.78 and the current share price of 0.9211 USD. Check the full fundamental report for a full analysis of the valuation metrics for SCNX.
The outstanding short interest for SCIENTURE HOLDINGS INC (SCNX) is 1.5% of its float. Check the ownership tab for more information on the SCNX short interest.
ChartMill assigns a technical rating of 1 / 10 to SCNX.
ChartMill assigns a fundamental rating of 2 / 10 to SCNX. SCNX has a bad profitability rating. Also its financial health evaluation is rather negative.
Over the last trailing twelve months SCNX reported a non-GAAP Earnings per Share(EPS) of 12.78. The EPS increased by 160.7% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 6631.89% | ||
ROA | 8.65% | ||
ROE | 11.47% | ||
Debt/Equity | 0.04 |
ChartMill assigns a Buy % Consensus number of 83% to SCNX. The Buy consensus is the average rating of analysts ratings from 7 analysts.